Back to Woodline Partners LP Woodline Partners LP

LXEOLXEO
10 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in LEXEO THERAPEUTICS INC

Woodline Partners LP holds 2.5M shares of LXEO (LEXEO THERAPEUTICS INC), worth $11.6M as of 2026-Q2. The position was decreased (-9.1% shares). LXEO represents 0.0% of Woodline Partners LP's portfolio.

Current Value

$11.6M

Current Shares

2.5M

Total Value Change

+$11.5M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.5M
-9.1%
$11.6M0.0%$4.66
0
2026-Q1
Decreased
2.8M
-14.0%
$15.8M0.1%$7.07
0
2025-Q4
Increased
3.2M
+24.3%
$31.8M0.1%$9.74
42
2025-Q3
Unchanged
2.6M
0.0%
$17.1M0.1%$6.66
0
2025-Q2
Increased
2.6M
+207.3%
$10.3M0.1%$4.12
45
2025-Q1
Decreased
837,014
-2.5%
$2.9M0.0%$4.10
0
2024-Q4
Increased
858,691
+0.8%
$5.7M0.0%$6.54
27
2024-Q3
Increased
851,961
+3.4%
$7.7M0.1%$9.11
28
2024-Q2
Increased
824,074
+6738.2%
$13.2M0.1%$16.04
54
2024-Q1
New
12,051
-
$188,9600.0%$15.68
31

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used